Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?

Patricio M. Aduriz-Lorenzo; Paula Aduriz-Llaneza; Javier Araiz-Iribarren; Munther A. Khamashta

doi:10.1177/0961203320919499

Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?

Patricio M. Aduriz-Lorenzo
, Paula Aduriz-Llaneza
, Javier Araiz-Iribarren
, Munther A. Khamashta

Dubai Hospital

P. J. Safarik University
University of the Basque Country
London Bridge Hospital

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Here, we review current hydroxychloroquine screening guidelines and controversies regarding specific screening tests and acceptance of the guidelines. Screening tests are described, and their predictive results are analysed, with special emphasis on early changes. Further research is needed to come to a conclusion about the efficacy of the new proposed dose.

Original language	English
Pages (from-to)	671-675
Number of pages	5
Journal	Lupus
Volume	29
Issue number	7
DOIs	https://doi.org/10.1177/0961203320919499
State	Published - 1 Jun 2020

Keywords

Hydroxychloroquine
chloroquine
maculopathy
retinal toxicity
retinopathy

Access to Document

10.1177/0961203320919499

Cite this

@article{c50d0866534a4aff8d7bb33942f5491f,

title = "Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?",

abstract = "Here, we review current hydroxychloroquine screening guidelines and controversies regarding specific screening tests and acceptance of the guidelines. Screening tests are described, and their predictive results are analysed, with special emphasis on early changes. Further research is needed to come to a conclusion about the efficacy of the new proposed dose.",

keywords = "Hydroxychloroquine, chloroquine, maculopathy, retinal toxicity, retinopathy",

author = "Aduriz-Lorenzo, \{Patricio M.\} and Paula Aduriz-Llaneza and Javier Araiz-Iribarren and Khamashta, \{Munther A.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2020.",

year = "2020",

month = jun,

day = "1",

doi = "10.1177/0961203320919499",

language = "English",

volume = "29",

pages = "671--675",

journal = "Lupus",

issn = "0961-2033",

publisher = "SAGE Publications Ltd",

number = "7",

}

TY - JOUR

T1 - Current opinion on hydroxychloroquine-related retinal toxicity screening

T2 - where do we stand now?

AU - Aduriz-Lorenzo, Patricio M.

AU - Aduriz-Llaneza, Paula

AU - Araiz-Iribarren, Javier

AU - Khamashta, Munther A.

N1 - Publisher Copyright: © The Author(s) 2020.

PY - 2020/6/1

Y1 - 2020/6/1

N2 - Here, we review current hydroxychloroquine screening guidelines and controversies regarding specific screening tests and acceptance of the guidelines. Screening tests are described, and their predictive results are analysed, with special emphasis on early changes. Further research is needed to come to a conclusion about the efficacy of the new proposed dose.

AB - Here, we review current hydroxychloroquine screening guidelines and controversies regarding specific screening tests and acceptance of the guidelines. Screening tests are described, and their predictive results are analysed, with special emphasis on early changes. Further research is needed to come to a conclusion about the efficacy of the new proposed dose.

KW - Hydroxychloroquine

KW - chloroquine

KW - maculopathy

KW - retinal toxicity

KW - retinopathy

UR - https://www.scopus.com/pages/publications/85084048924

U2 - 10.1177/0961203320919499

DO - 10.1177/0961203320919499

M3 - Article

C2 - 32316844

AN - SCOPUS:85084048924

SN - 0961-2033

VL - 29

SP - 671

EP - 675

JO - Lupus

JF - Lupus

IS - 7

ER -

Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this